Table 4.
Comparison between loss to follow-up exclusively and unfavorable outcomes (loss to follow-up, deaths, and failure) in the multivariate regression
| Characteristic | Loss to follow-up | Unfavorable outcomes | ||
|---|---|---|---|---|
| aOR (95% CI) | P-value | aOR (95% CI) | P-value | |
| Age (years) | ||||
| 10–14 | Reference | – | – | – |
| 15–16 | 0.53 (2.49–1.14) | 0.105 | 0.54 (0.26–1.10) | 0.091 |
| 17–18 | 1.15 (0.61–2.19) | 0.666 | 1.20 (0.65–2.21) | 0.552 |
| Type of TB | ||||
| New case | Reference | – | – | – |
| Retreatment | 3.90 (1.80–8.47) | 0.001 | 4.51 (2.23–9.17) | < 0.001 |
| Residence area/districts | ||||
| 2.0 | Reference | – | – | – |
| 3.1 | 4.73 (1.91–11.69) | 0.001 | 4.11 (1.79–9.46) | < 0.001 |
| 3.3 | 5.83 (2.21–15.38) | < 0.001 | 5.35 (2.20–13.03) | < 0.001 |
| Other | 1.85 (0.78–4.41) | 0.160 | 1.77 (0.81–3.87) | 1.159 |
| TB–HIV coinfection | ||||
| HIV negative | Reference | – | – | – |
| HIV positive | 6.09 (2.12–17.49) | 0.001 | 10.15 (4.15–25.34) | < 0.001 |
| Not performed/missing data | 1.10 (0.58–2.08) | 0.781 | 1.02 (0.54–1.89) | 0.970 |
| Extreme vulnerability | ||||
| No | Reference | – | – | – |
| Yes | 3.00 (1.65–5.4) | < 0.001 | 3.01 (1.70–5.33) | < 0.001 |
| Direct observed treatment | ||||
| No | Reference | – | – | – |
| Yes | 1.15 (0.60–2.19) | 0.656 | 1.10 (0.61–1.97) | 0.749 |
| Missing data | 2.40 (1.17–4.90) | 0.016 | 2.48 (1.31–4.96) | 0.006 |
aOR = adjusted odds ratio; TB = tuberculosis.